DK1642987T3 - Nucleotidsekvenser dannet ud fra genomerne af retrovirusserne HIV-1, HIV-2 og SIV samt deres anvendelse til opformering af disse virale genomer samt til en vitro-diagnose af infektioner, der stammer fra disse virusser - Google Patents

Nucleotidsekvenser dannet ud fra genomerne af retrovirusserne HIV-1, HIV-2 og SIV samt deres anvendelse til opformering af disse virale genomer samt til en vitro-diagnose af infektioner, der stammer fra disse virusser

Info

Publication number: DK1642987T3
Authority: DK; Denmark
Prior art keywords: hiv; gene; nucleic acid; siv; sequence
Prior art date: 1989-06-02

Application number

DK05014676T

Other languages

English (en)

Inventor

Maurice Moncany

Luc Montagnier

Original Assignee

Pasteur Institut

Inst Nat Sante Rech Med

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-06-02

Filing date

1990-06-05

Publication date

2008-12-01

1989-06-02 Priority claimed from FR8907354A external-priority patent/FR2647809B1/fr

1989-09-20 Priority claimed from FR8912371A external-priority patent/FR2652091B1/fr

1990-06-05 Application filed by Pasteur Institut, Inst Nat Sante Rech Med filed Critical Pasteur Institut

2008-12-01 Application granted granted Critical

2008-12-01 Publication of DK1642987T3 publication Critical patent/DK1642987T3/da

Links

241000713772 Human immunodeficiency virus 1 Species 0.000 title abstract 13
208000031886 HIV Infections Diseases 0.000 title abstract 7
241000713340 Human immunodeficiency virus 2 Species 0.000 title abstract 7
241000700605 Viruses Species 0.000 title abstract 6
108091028043 Nucleic acid sequence Proteins 0.000 title 1
238000003745 diagnosis Methods 0.000 title 1
238000000338 in vitro Methods 0.000 title 1
208000015181 infectious disease Diseases 0.000 title 1
230000001902 propagating effect Effects 0.000 title 1
241001430294 unidentified retrovirus Species 0.000 title 1
230000003612 virological effect Effects 0.000 title 1
108090000623 proteins and genes Proteins 0.000 abstract 10
108020004707 nucleic acids Proteins 0.000 abstract 8
150000007523 nucleic acids Chemical class 0.000 abstract 8
102000039446 nucleic acids Human genes 0.000 abstract 8
239000013615 primer Substances 0.000 abstract 7
239000012472 biological sample Substances 0.000 abstract 5
230000004544 DNA amplification Effects 0.000 abstract 3
230000015572 biosynthetic process Effects 0.000 abstract 3
238000004925 denaturation Methods 0.000 abstract 3
230000036425 denaturation Effects 0.000 abstract 3
108010014303 DNA-directed DNA polymerase Proteins 0.000 abstract 2
102000016928 DNA-directed DNA polymerase Human genes 0.000 abstract 2
230000000295 complement effect Effects 0.000 abstract 2
238000001514 detection method Methods 0.000 abstract 2
238000000034 method Methods 0.000 abstract 2
235000011178 triphosphate Nutrition 0.000 abstract 2
239000001226 triphosphate Substances 0.000 abstract 2
UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 abstract 2
108020004635 Complementary DNA Proteins 0.000 abstract 1
239000003155 DNA primer Substances 0.000 abstract 1
102100034343 Integrase Human genes 0.000 abstract 1
108091034117 Oligonucleotide Proteins 0.000 abstract 1
108010092799 RNA-directed DNA polymerase Proteins 0.000 abstract 1
230000003321 amplification Effects 0.000 abstract 1
238000010804 cDNA synthesis Methods 0.000 abstract 1
239000003153 chemical reaction reagent Substances 0.000 abstract 1
239000002299 complementary DNA Substances 0.000 abstract 1
238000000605 extraction Methods 0.000 abstract 1
238000009396 hybridization Methods 0.000 abstract 1
238000003199 nucleic acid amplification method Methods 0.000 abstract 1
239000002777 nucleoside Substances 0.000 abstract 1
125000003835 nucleoside group Chemical group 0.000 abstract 1
239000002773 nucleotide Substances 0.000 abstract 1
125000003729 nucleotide group Chemical group 0.000 abstract 1
239000000523 sample Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/702—Specific hybridization probes for retroviruses
- C12Q1/703—Viruses associated with AIDS
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
- G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
- G01N2333/16—HIV-1, HIV-2
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/974—Aids related test
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Virology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Immunology (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Medicinal Chemistry (AREA)
AIDS & HIV (AREA)
Bioinformatics & Cheminformatics (AREA)
Biotechnology (AREA)
Gastroenterology & Hepatology (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
General Engineering & Computer Science (AREA)
Microbiology (AREA)
Communicable Diseases (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Tropical Medicine & Parasitology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)
Saccharide Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK05014676T 1989-06-02 1990-06-05 Nucleotidsekvenser dannet ud fra genomerne af retrovirusserne HIV-1, HIV-2 og SIV samt deres anvendelse til opformering af disse virale genomer samt til en vitro-diagnose af infektioner, der stammer fra disse virusser DK1642987T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR8907354A FR2647809B1 (fr)	1989-06-02	1989-06-02	Amorces oligonucleotidiques pour l'amplification du genome des retrovirus du type hiv-1, hiv-2 et siv, et leurs applications au diagnostic in vitro des infections dues a ces virus
FR8912371A FR2652091B1 (fr)	1989-09-20	1989-09-20	Sequences nucleotidiques issues du genome des retrovirus du type hiv-1, hiv-2 et siv, et leurs applications notamment pour l'amplification des genomes de ces retrovirus et pour le diagnostic in-vitro des infections dues a ces virus.
PCT/FR1990/000393 WO1990015066A2 (fr)	1989-06-02	1990-06-05	Sequences nucleotidiques issues du genome des retrovirus du type hiv-1, hiv-2 et siv, et leurs applications notamment pour l'amplification des genomes de ces retrovirus et pour le diagnostic in vitro des infections dues a ces virus

Publications (1)

Publication Number	Publication Date
DK1642987T3 true DK1642987T3 (da)	2008-12-01

Family

ID=26227366

Family Applications (5)

Application Number	Title	Priority Date	Filing Date
DK05014676T DK1642987T3 (da)	1989-06-02	1990-06-05	Nucleotidsekvenser dannet ud fra genomerne af retrovirusserne HIV-1, HIV-2 og SIV samt deres anvendelse til opformering af disse virale genomer samt til en vitro-diagnose af infektioner, der stammer fra disse virusser
DK97110543T DK0806484T3 (da)	1989-06-02	1990-06-05	Syntese af proteiner eller polypeptider kodet af en nucleotidsekvens af HIV-1, HIV-2 eller SIV.
DK07025195.4T DK2011888T3 (da)	1989-06-02	1990-06-05	Nukleotidsekvenser resulterende fra genomet af HIV-1-, og SIV-retroviraene og deres anvendelser til især apmplifikation af genomerne af disse retrovira og til in vitro-diagnose af infektioner forårsaget af disse vira
DK90401520T DK0403333T3 (da)	1989-06-02	1990-06-05	Nukleotidsekvenser stammende fra genomet i retrovirus af typen HIV-1, HIV-2 og SIV og deres anvendelse, fortrinsvis til opf
DK06013029T DK1715064T3 (da)	1989-06-02	1990-06-05	Nucleotidsekvenser fra HIV-1-, HIV-2- og SIV-retrovirusgenomer samt deres anvendelse til mangfoldiggörelse af pol-sekvenser fra disse retrovira og til diagnosticering in vitro af infektioner fremkaldt af disse vira

Family Applications After (4)

Application Number	Title	Priority Date	Filing Date
DK97110543T DK0806484T3 (da)	1989-06-02	1990-06-05	Syntese af proteiner eller polypeptider kodet af en nucleotidsekvens af HIV-1, HIV-2 eller SIV.
DK07025195.4T DK2011888T3 (da)	1989-06-02	1990-06-05	Nukleotidsekvenser resulterende fra genomet af HIV-1-, og SIV-retroviraene og deres anvendelser til især apmplifikation af genomerne af disse retrovira og til in vitro-diagnose af infektioner forårsaget af disse vira
DK90401520T DK0403333T3 (da)	1989-06-02	1990-06-05	Nukleotidsekvenser stammende fra genomet i retrovirus af typen HIV-1, HIV-2 og SIV og deres anvendelse, fortrinsvis til opf
DK06013029T DK1715064T3 (da)	1989-06-02	1990-06-05	Nucleotidsekvenser fra HIV-1-, HIV-2- og SIV-retrovirusgenomer samt deres anvendelse til mangfoldiggörelse af pol-sekvenser fra disse retrovira og til diagnosticering in vitro af infektioner fremkaldt af disse vira

Country Status (11)

Country	Link
US (6)	US5688637A (da)
EP (5)	EP0806484B1 (da)
JP (2)	JP3428012B2 (da)
AT (5)	ATE423856T1 (da)
CA (3)	CA2585164C (da)
DE (7)	DE69034267D1 (da)
DK (5)	DK1642987T3 (da)
ES (5)	ES2321326T3 (da)
GR (1)	GR3032261T3 (da)
SG (1)	SG47868A1 (da)
WO (1)	WO1990015066A2 (da)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7022814B1 (en)	1992-01-21	2006-04-04	Institut Pasteur And Institut National De La Sante Et De La Recherche Medicale	Nucleotide sequences derived from the genome of retroviruses of the HIV-1, HIV-2 and SIV type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the diseases due to these viruses
ATE423856T1 (de) *	1989-06-02	2009-03-15	Pasteur Institut	Nukleotid-sequenzen von hiv-1, hiv-2 und siv retrovirusgenomen, ihre verwendung zur amplifizierung von pol-sequenzen dieser retroviren und zur in vitro diagnostik von diesen viren verursachten infektionen
US5856088A (en) *	1989-07-11	1999-01-05	Gen-Probe Incorporated	Detection of human immunodeficiency virus type 1
US6589734B1 (en)	1989-07-11	2003-07-08	Gen-Probe Incorporated	Detection of HIV
JPH04152899A (ja) *	1990-10-17	1992-05-26	Shionogi & Co Ltd	２段階ｐｃｒ法によるｈｉｖ―１ゲノムの検出法およびオリゴヌクレオチド
FR2677039B1 (fr) *	1991-05-31	1994-09-09	Cis Bio Int	Oligonucleotides, utilisables comme reactifs pour la detection in vitro des infections a retrovirus de type hiv et procede de detection de retrovirus de type hiv.
CA2124797C (en) *	1991-12-23	2004-03-30	Bruce D. Irvine	Hiv probes for use in solution phase sandwich hybridization assays
FR2692279B1 (fr) *	1992-06-16	1995-05-19	Centre Nat Rech Scient	Séquences nucléotidiques issues de la souche WO du vif et leurs fragments, applications desdites séquences à l'expression de peptides immunogènes et au diagnostic de l'immunodéficience féline.
KR100325554B1 (ko)	1993-03-26	2002-11-02	젠-프로브 인코포레이티드	사람의면역결핍 바이러스타입1의검출
AU7568794A (en) *	1993-08-20	1995-03-21	St. Luke's-Roosevelt Hospital Center	Hiv (vif)-related compositions, and prophylactic and therapeutic uses thereof
US5733781A (en) *	1994-07-19	1998-03-31	Gen-Probe Incorporated	Oligonucleotides and methods for inhibiting propagation of human immunodeficiency virus
CA2239027A1 (en)	1995-12-05	1997-06-12	David J. Phipps	Methods for the early detection of hiv infection
US6265152B1 (en) *	1995-12-22	2001-07-24	Visible Genetics Inc.	Method and kit for evaluation of HIV mutations
DE19644248A1 (de) *	1996-10-24	1998-04-30	Boehringer Mannheim Gmbh	Primer und Probes zum Nachweis von HIV
US6830887B2 (en)	1997-03-18	2004-12-14	Bayer Healthcare Llc	Method and kit for quantitation and nucleic acid sequencing of nucleic acid analytes in a sample
US5962665A (en) *	1997-06-16	1999-10-05	Abbott Laboratories	Nucleic acid primers and probes for detecting HIV-1 and HIV-2
US6001558A (en) *	1997-06-25	1999-12-14	Ortho Clinical Diagnostics, Inc.	Amplification and detection of HIV-1 and/or HIV 2
EP1017856A1 (en) *	1997-09-26	2000-07-12	Visible Genetics Inc.	Method and kit for evaluation of hiv mutations
US6228128B1 (en)	1997-11-10	2001-05-08	Charlotte Johansen	Antimicrobial activity of laccases
DE19850186A1 (de) *	1998-10-30	2000-05-25	Roche Diagnostics Gmbh	Neue Primer und Sonden zum Nachweis von HIV
US6303293B1 (en)	1999-02-02	2001-10-16	Ortho-Clinical Diagnostics, Inc.	Oligonucleotide reverse transcription primers for efficient detection of HIV-1 and HIV-2 and methods of use thereof
WO2000046403A2 (en) *	1999-02-03	2000-08-10	THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OFHEALT H AND HUMAN SERVICES	Methods and reagents for molecular detection of hiv-1 groups m, n and o
DE19908766C2 (de) *	1999-02-19	2001-02-15	Ulrich Schubert	Verwendung synthetischer Vpr-Peptide des Humanen Immundefizienzvirus Typ 1 (HIV-1) zur Entwicklung von therapeutischen und diagnostischen Reagenzien
WO2000068436A1 (en) *	1999-05-07	2000-11-16	Nationales Zentrum Für Retroviren	Detection system for human immunodeficiency virus based on nucleic acid amplification
FR2798385B1 (fr) *	1999-06-21	2003-09-05	Bio Merieux	Procede de recherche d'une resistance aux anti-proteases chez des souches du virus vih-2
JP4824236B2 (ja)	1999-07-09	2011-11-30	ジェン−プローブ・インコーポレーテッド	核酸増幅によるｈｉｖ−１の検出
US20030228600A1 (en) *	2000-07-14	2003-12-11	Eppendorf 5 Prime, Inc.	DNA isolation method and kit
CA2731495C (en) *	2000-09-01	2015-02-03	Gen-Probe Incorporated	Amplification of hiv-1 sequences for detection of sequences associated with drug-resistance mutations
US6582920B2 (en)	2000-09-01	2003-06-24	Gen-Probe Incorporated	Amplification of HIV-1 RT sequences for detection of sequences associated with drug-resistance mutations
EP1399585B1 (en)	2000-10-23	2008-02-20	Gen-Probe Incorporated	Compositions and methods for detecting human immunodeficiency virus 2 (hiv-2)
US6770752B2 (en)	2001-01-09	2004-08-03	Becton, Dickinson And Company	Sequences for detection of HIV-1
DE60233871D1 (de) *	2001-03-05	2009-11-12	Siemens Healthcare Diagnostics	Verfahren und primer zur analyse von hiv-1-mutationen
JP4701532B2 (ja) *	2001-04-26	2011-06-15	東ソー株式会社	Ｈｉｖ−１ｒｎａの増幅および検出法
US6852491B2 (en) *	2001-09-04	2005-02-08	Abbott Laboratories	Amplification and detection reagents for HIV-1
EP1455813B1 (en) *	2001-12-18	2015-07-15	mondoBIOTECH AG	Interferon gamma in combination with a diagnostic array for use in the improved treatment of idiopathic pulmonary fibrosis
WO2003062377A2 (en) *	2002-01-17	2003-07-31	The Uab Research Foundation	COMPLETE GENOME SEQUENCE OF SIVcpzTAN1
CN1301263C (zh)	2002-12-18	2007-02-21	北京昭衍新药研究中心	一组抗hiv感染及防治艾滋病的核苷酸序列及其应用
US20050222068A1 (en)	2003-10-23	2005-10-06	Mourich Dan V	Method and antisense composition for selective inhibition of HIV infection in hematopoietic cells
EP2251442B9 (en) *	2003-12-19	2012-04-25	Gen-Probe Incorporated	Compositions, methods and kits for detecting the nucleic acids of HIV-1 and HIV-2
TW200613554A (en)	2004-06-17	2006-05-01	Wyeth Corp	Plasmid having three complete transcriptional units and immunogenic compositions for inducing an immune response to HIV
US7993647B2 (en)	2004-07-01	2011-08-09	The United States Of America As Represented By The Department Of Health And Human Services	Monoclonal antibodies to HIV-1 and methods of using same
ES2610781T3 (es)	2004-09-14	2017-05-03	Argos Therapeutics, Inc.	Amplificación de patógenos independiente de la cepa y vacunas para estos
US20090050492A1 (en) *	2005-08-02	2009-02-26	Board Of Trustees Of Michigan State University	Nanoporous silicon-based electrochemical nucleic acid biosensor
US8617816B2 (en) *	2007-03-16	2013-12-31	454 Life Sciences, A Roche Company	System and method for detection of HIV drug resistant variants
US8221981B2 (en) *	2007-07-30	2012-07-17	Argos Therapeutics, Inc.	Primers and probes for the amplification and detection of HIV Gag, Rev and Nef polynucleotides
US8405379B1 (en)	2008-09-18	2013-03-26	Luc Montagnier	System and method for the analysis of DNA sequences in biological fluids
US10545149B2 (en) *	2008-10-06	2020-01-28	Morehouse School Of Medicine	Detection of HIV-related proteins in urine
EP2376633A1 (en)	2008-12-17	2011-10-19	AVI BioPharma, Inc.	Antisense compositions and methods for modulating contact hypersensitivity or contact dermatitis
AU2011230619C1 (en)	2010-03-25	2016-06-23	Oregon Health & Science University	CMV glycoproteins and recombinant vectors
HUE037408T2 (hu)	2011-06-10	2018-08-28	Univ Oregon Health & Science	CMV glikoproteinek és rekombináns vektorok
CN102964898B (zh)	2011-08-05	2016-05-25	罗门哈斯公司	具有改进的亲水污渍排斥性的水性涂料组合物
CA2789539A1 (en)	2011-09-12	2013-03-12	International Aids Vaccine Initiative	Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
US9402894B2 (en)	2011-10-27	2016-08-02	International Aids Vaccine Initiative	Viral particles derived from an enveloped virus
ES2631608T3 (es)	2012-06-27	2017-09-01	International Aids Vaccine Initiative	Variante de la glicoproteína Env del VIH-1
EP2848937A1 (en)	2013-09-05	2015-03-18	International Aids Vaccine Initiative	Methods of identifying novel HIV-1 immunogens
US10058604B2 (en)	2013-10-07	2018-08-28	International Aids Vaccine Initiative	Soluble HIV-1 envelope glycoprotein trimers
EP3069730A3 (en)	2015-03-20	2017-03-15	International Aids Vaccine Initiative	Soluble hiv-1 envelope glycoprotein trimers
US9931394B2 (en)	2015-03-23	2018-04-03	International Aids Vaccine Initiative	Soluble HIV-1 envelope glycoprotein trimers

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0387915B1 (en)	1984-10-18	1993-03-10	Institut Pasteur	F antigens of the human immunodeficiency virus, and their applications
US5386022A (en)	1985-03-28	1995-01-31	Hoffman-La Roche Inc.	Primes and probes for the amplification and detection of aids associated nucleic acids
US5008182A (en)	1986-01-10	1991-04-16	Cetus Corporation	Detection of AIDS associated virus by polymerase chain reaction
ES8706823A1 (es)	1985-03-28	1987-06-16	Cetus Corp	Un procedimiento para detectar la presencia o ausencia de al menos una secuencia especifica de acidos nucleicos en una muestra
AU606043B2 (en)	1985-03-28	1991-01-31	F. Hoffmann-La Roche Ag	Detection of viruses by amplification and hybridization
US5176995A (en)	1985-03-28	1993-01-05	Hoffmann-La Roche Inc.	Detection of viruses by amplification and hybridization
US4683195A (en) *	1986-01-30	1987-07-28	Cetus Corporation	Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US5008185A (en)	1985-11-04	1991-04-16	Cell Analysis Systems, Inc.	Methods and apparatus for the quantitation of nuclear proteins
US4839288A (en) *	1986-01-22	1989-06-13	Institut Pasteur	Retrovirus capable of causing AIDS, antigens obtained from this retrovirus and corresponding antibodies and their application for diagnostic purposes
EP0239425B1 (fr) *	1986-01-22	1989-11-02	Institut Pasteur	Rétrovirus du type HIV-2 susceptible de provoquer le SIDA, et ses constituants antigéniques et nucléiques
US4806463A (en) *	1986-05-23	1989-02-21	Worcester Foundation For Experimental Biology	Inhibition of HTLV-III by exogenous oligonucleotides
US5824482A (en) *	1986-06-23	1998-10-20	Institut Pasteur	Purification, cloning, and characterization of a novel human immunodeficiency virus LAVMAL
US5030714A (en) *	1986-06-23	1991-07-09	Institut Pasteur	Variant of LAV viruses
WO1988001302A1 (en) *	1986-08-11	1988-02-25	Siska Diagnostics, Inc.	Nucleic acid probe assay methods and compositions
EP0269520A3 (fr) *	1986-11-21	1988-08-24	Institut Pasteur	Rétrovirus du type HIV-2 susceptible de provoquer le sida, et ses constituants antigéniques et nucléiques
US5079351A (en) *	1986-11-26	1992-01-07	Cetus Corporation	Oligonucleotides and kits for detection of htlvi and htlvii viruses by hybridization
US5268268A (en)	1986-11-26	1993-12-07	Hoffmann-La Roche Inc.	Detection of HTLVI and HTLVII viruses by hybridization
EP0272098A3 (en) *	1986-12-15	1990-06-06	City Of Hope National Medical Center	Method for amplification and detection of rna sequences
JP2948823B2 (ja) *	1987-01-16	1999-09-13	アンステイテユ・パストウール	ヒト免疫不全レトロウィルス（ｈｉｖ）関連抗原性ペプチド、そのウィルス感染の検出及びワクチンへの使用
WO1989001050A1 (en)	1987-07-31	1989-02-09	The Board Of Trustees Of The Leland Stanford Junior University	Selective amplification of target polynucleotide sequences
US4963532A (en)	1987-11-25	1990-10-16	Hem Research, Inc.	dsRNA-based prevention of viral escape
US5389512A (en)	1988-10-07	1995-02-14	Hoffman-La Roche Inc.	Method for determining the relative amount of a viral nucleic acid segment in a sample by the polymerase chain reaction
FR2647856B1 (fr) *	1989-05-31	1994-03-04	Framatome	Dispositif auxiliaire de relachement commande a distance pour un mecanisme a action positive
ATE423856T1 (de)	1989-06-02	2009-03-15	Pasteur Institut	Nukleotid-sequenzen von hiv-1, hiv-2 und siv retrovirusgenomen, ihre verwendung zur amplifizierung von pol-sequenzen dieser retroviren und zur in vitro diagnostik von diesen viren verursachten infektionen

1990
- 1990-06-05 AT AT06013029T patent/ATE423856T1/de not_active IP Right Cessation
- 1990-06-05 ES ES06013029T patent/ES2321326T3/es not_active Expired - Lifetime
- 1990-06-05 CA CA002585164A patent/CA2585164C/fr not_active Expired - Lifetime
- 1990-06-05 DK DK05014676T patent/DK1642987T3/da active
- 1990-06-05 ES ES97110543T patent/ES2262166T3/es not_active Expired - Lifetime
- 1990-06-05 AT AT05014676T patent/ATE404699T1/de not_active IP Right Cessation
- 1990-06-05 EP EP97110543A patent/EP0806484B1/fr not_active Expired - Lifetime
- 1990-06-05 DE DE69034267T patent/DE69034267D1/de not_active Expired - Lifetime
- 1990-06-05 JP JP50891190A patent/JP3428012B2/ja not_active Expired - Lifetime
- 1990-06-05 AT AT07025195T patent/ATE466111T1/de not_active IP Right Cessation
- 1990-06-05 DE DE05014676T patent/DE05014676T1/de active Pending
- 1990-06-05 AT AT90401520T patent/ATE185379T1/de not_active IP Right Cessation
- 1990-06-05 DE DE69033311T patent/DE69033311T2/de not_active Expired - Lifetime
- 1990-06-05 CA CA002062829A patent/CA2062829C/fr not_active Expired - Lifetime
- 1990-06-05 EP EP06013029A patent/EP1715064B1/fr not_active Expired - Lifetime
- 1990-06-05 CA CA002685262A patent/CA2685262A1/fr not_active Abandoned
- 1990-06-05 DE DE69034265T patent/DE69034265D1/de not_active Expired - Lifetime
- 1990-06-05 DK DK97110543T patent/DK0806484T3/da active
- 1990-06-05 SG SG1996004845A patent/SG47868A1/en unknown
- 1990-06-05 DE DE07025195T patent/DE07025195T1/de active Pending
- 1990-06-05 ES ES07025195T patent/ES2315215T1/es active Pending
- 1990-06-05 DK DK07025195.4T patent/DK2011888T3/da active
- 1990-06-05 EP EP07025195A patent/EP2011888B1/fr not_active Expired - Lifetime
- 1990-06-05 EP EP90401520A patent/EP0403333B1/fr not_active Expired - Lifetime
- 1990-06-05 AT AT97110543T patent/ATE323183T1/de not_active IP Right Cessation
- 1990-06-05 DK DK90401520T patent/DK0403333T3/da active
- 1990-06-05 WO PCT/FR1990/000393 patent/WO1990015066A2/fr not_active Ceased
- 1990-06-05 ES ES05014676T patent/ES2275451T3/es not_active Expired - Lifetime
- 1990-06-05 DK DK06013029T patent/DK1715064T3/da active
- 1990-06-05 ES ES90401520T patent/ES2139567T3/es not_active Expired - Lifetime
- 1990-06-05 DE DE69034220T patent/DE69034220T2/de not_active Expired - Lifetime
- 1990-06-05 DE DE69034260T patent/DE69034260D1/de not_active Expired - Lifetime
- 1990-06-05 EP EP05014676A patent/EP1642987B1/fr not_active Expired - Lifetime
1993
- 1993-12-02 US US08/160,465 patent/US5688637A/en not_active Expired - Fee Related
1995
- 1995-06-07 US US08/472,928 patent/US7078516B1/en not_active Expired - Lifetime
1997
- 1997-07-16 US US08/895,231 patent/US5786177A/en not_active Expired - Lifetime
1998
- 1998-06-05 US US09/092,077 patent/US6194142B1/en not_active Expired - Lifetime
1999
- 1999-09-24 JP JP11270165A patent/JP2000093187A/ja active Pending
- 1999-12-28 GR GR990403346T patent/GR3032261T3/el unknown
2004
- 2004-06-08 US US10/862,363 patent/US7759477B2/en not_active Expired - Lifetime
2005
- 2005-08-15 US US11/203,127 patent/US7777020B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
EP1642987A3 (fr)	2006-08-23
US7759477B2 (en)	2010-07-20
ES2315215T1 (es)	2009-04-01
ATE423856T1 (de)	2009-03-15
EP0403333B1 (fr)	1999-10-06
DE69033311T2 (de)	2000-02-17
DE69034265D1 (de)	2009-04-09
EP0403333A2 (fr)	1990-12-19
US5786177A (en)	1998-07-28
ES2275451T1 (es)	2007-06-16
CA2062829A1 (fr)	1990-12-03
JPH04507043A (ja)	1992-12-10
ES2275451T3 (es)	2009-02-16
DK2011888T3 (da)	2010-08-09
US20060035260A1 (en)	2006-02-16
JP2000093187A (ja)	2000-04-04
EP2011888B1 (fr)	2010-04-28
ATE404699T1 (de)	2008-08-15
ATE323183T1 (de)	2006-04-15
DE69034260D1 (de)	2008-09-25
EP0806484A3 (fr)	2000-09-13
US20050037340A1 (en)	2005-02-17
CA2062829C (fr)	2007-08-07
EP0403333A3 (fr)	1991-11-21
EP2011888A1 (fr)	2009-01-07
CA2585164A1 (fr)	1990-12-13
EP0806484A2 (fr)	1997-11-12
DE69033311D1 (de)	1999-11-11
SG47868A1 (en)	1998-04-17
ATE185379T1 (de)	1999-10-15
US7078516B1 (en)	2006-07-18
EP1715064B1 (fr)	2009-02-25
ATE466111T1 (de)	2010-05-15
EP1715064A8 (fr)	2007-05-16
DE69034220T2 (de)	2006-12-28
DK1715064T3 (da)	2009-06-22
ES2139567T3 (es)	2000-02-16
EP1715064A1 (fr)	2006-10-25
EP0806484B1 (fr)	2006-04-12
ES2262166T3 (es)	2006-11-16
DK0403333T3 (da)	2000-03-20
EP1642987A2 (fr)	2006-04-05
HK1097574A1 (en)	2007-06-29
GR3032261T3 (en)	2000-04-27
US7777020B2 (en)	2010-08-17
JP3428012B2 (ja)	2003-07-22
ES2321326T3 (es)	2009-06-04
WO1990015066A2 (fr)	1990-12-13
HK1125136A1 (en)	2009-07-31
WO1990015066A3 (fr)	1991-04-18
DE07025195T1 (de)	2009-05-07
CA2585164C (fr)	2010-02-02
US6194142B1 (en)	2001-02-27
EP1642987B1 (fr)	2008-08-13
CA2685262A1 (fr)	1990-12-13
US5688637A (en)	1997-11-18
HK1092839A1 (zh)	2007-02-16
DE69034220D1 (de)	2006-05-24
DK0806484T3 (da)	2006-08-14
DE69034267D1 (de)	2010-06-10
DE05014676T1 (de)	2007-05-10

Publication	Publication Date	Title
DK1642987T3 (da)	2008-12-01	Nucleotidsekvenser dannet ud fra genomerne af retrovirusserne HIV-1, HIV-2 og SIV samt deres anvendelse til opformering af disse virale genomer samt til en vitro-diagnose af infektioner, der stammer fra disse virusser
US5389512A (en)	1995-02-14	Method for determining the relative amount of a viral nucleic acid segment in a sample by the polymerase chain reaction
Kwoh et al.	1989	Transcription-based amplification system and detection of amplified human immunodeficiency virus type 1 with a bead-based sandwich hybridization format.
KR0148265B1 (ko)	1998-10-15	자가-지속 서열 복제 시스템
JP3802110B2 (ja)	2006-07-26	核酸の同時増幅方法並びにそのための組成物、試験キット及び試験装置
ES2445495T3 (es)	2014-03-03	Cebadores de ácido nucleico y sondas para detectar VIH-1 y VIH-2
KR100901084B1 (ko)	2009-06-08	Ｈｉｖ-1 및 ｈｉｖ-2를 효율적으로 검출하기 위한 올리고뉴클레오타이드 역전사 프라이머, 이의 사용 방법 및 이를 포함하는 키트
JP3689333B2 (ja)	2005-08-31	Ｈｉｖ−１の全てのサブタイプを増幅及び検出するためにプライマー及びプローブとして使用できる核酸配列
JP2021511802A5 (da)	2022-02-02
JPH08242898A (ja)	1996-09-24	免疫不全ウイルス−１型増幅用プライマー
KR870007427A (ko)	1987-08-19	증폭 및 하이브리드화로 바이러스를 검출하는 방법
Frank et al.	1991	Kinetic interaction of human immunodeficiency virus type 1 reverse transcriptase with the antiviral tetrahydroimidazo [4, 5, 1-jk]-[1, 4]-benzodiazepine-2-(1H)-thione compound, R82150
RU98100921A (ru)	1999-12-10	Праймеры для обнаружения вич-1
CN114369649A (zh)	2022-04-19	一种特异的选择扩增及多重pcr方法和应用
Thomas et al.	2007	Determination of the ex vivo rates of human immunodeficiency virus type 1 reverse transcription by using novel strand-specific amplification analysis
JP2023520590A5 (da)	2024-04-10
JP2004500014A (ja)	2004-01-08	Ｈｉｖを検出するための新規のプライマーおよびプローブ
JP2020146066A5 (da)	2021-02-12
JP6164590B2 (ja)	2017-07-19	ウシ白血病ウイルス検出用プライマーセット、及びその利用
US20220220536A1 (en)	2022-07-14	Compositions and methods of using a dna nanoswitch for the detection of rna
ES2336807T3 (es)	2010-04-16	Deteccion del tipo y subtipo del vih.
WO2019046783A1 (en)	2019-03-07	METHODS OF MAKING AND USING TANDEM MOLECULES WITH DOUBLE BAR CODES
JP2007135469A (ja)	2007-06-07	核酸増幅方法
JP2023516683A5 (da)	2024-04-16
DK200401109A (da)	2004-07-15	Kit til multiplicering og påvisning af nukleinsyresekvenser